Eris Lifesciences Limited
Eris Lifesciences Limited (ERIS-EQ) live share price today at NSE / BSE
Thu, 17 Sept 2026, 02:27 PM
About ERIS-EQ
Eris Lifesciences Ltd is a leading Indian pharmaceutical company with a primary focus on the chronic and acute segments, including cardiovascular, anti-diabetic, gastroenterology, and neuropsychiatry therapies. Established in 2007 and headquartered in Ahmedabad, Eris specializes in branded formulations with a doctor- and patient-centric approach, leveraging a robust product portfolio and a deep presence in the Indian ethical pharma market. The company has continually expanded its offerings through in-house R&D, acquisitions, and collaborations, maintaining a strong presence among prescription-focused specialists and super-specialists.
52 Week Range
Current Signal
green
Open
INR 1,296.00
High
INR 1,350.00
Low
INR 1,290.60
Prev. Close
INR 1,303.20
Volume
44,936
Avg. Volume (7D)
31,729
Avg. Volume (10D)
41,052
Latest Signal
BuyBuy Price
INR 1341.0
Close Price
INR 1350.0
Change
0.67%
Stoploss
INR 1300.8
Signal Date
2026-09-17
Hold
Yes
Pattern
Morning Star
Company Snapshot
| CIN | L24232GJ2007PLC049867 |
| Industry | Pharmaceuticals |
| Market Lot | 1 |
| Impact Cost | 0.08% |
| Listing Date | 28 Jun 2017 |
| BC Record Date | RD 13/02/2025 |
| Registered Address | 8th floor, Commerce House IV, Beside Shall Petrol Pump, 100 Feet Road, Prahladnagar |
| Auditor | M/s Deloitte Haskins & Sells LLP |
Registrar
Shareholding Pattern
Quarterly filing · 30 Jun 2026
Board of Directors
Today Share Price
Eris Lifesciences Limited
| Particulars | Details |
|---|---|
| Opening Price | INR 1,296.00 |
| Previous Closing Price | INR 1,303.20 |
| Volume of Eris Lifesciences Limited | 44,936 |
| Value of Share | — |
Today NSE Share Price
Eris Lifesciences Limited
| Particulars | Details |
|---|---|
| Live Share Price NSE India | INR 1,350.00 |
| Previous Closing Price | INR 1,303.20 |
| Open Price | INR 1,296.00 |
| High | INR 1,350.00 |
| Low | INR 1,290.60 |
Today BSE Share Price
Eris Lifesciences Limited
| Particulars | Details |
|---|---|
| Live Share Price BSE India | INR 1,350.00 |
| Previous Closing Price | INR 1,303.20 |
| Open Price | INR 1,296.00 |
| High | INR 1,350.00 |
| Low | INR 1,290.60 |
Eris Lifesciences Limited
Eris Lifesciences Ltd is a leading Indian pharmaceutical company with a primary focus on the chronic and acute segments, including cardiovascular, anti-diabetic, gastroenterology, and neuropsychiatry therapies. Established in 2007 and headquartered in Ahmedabad, Eris specializes in branded formulations with a doctor- and patient-centric approach, leveraging a robust product portfolio and a deep presence in the Indian ethical pharma market. The company has continually expanded its offerings through in-house R&D, acquisitions, and collaborations, maintaining a strong presence among prescription-focused specialists and super-specialists.
With state-of-the-art manufacturing facilities in Gujarat and Assam, Eris Lifesciences ensures high-quality production standards and supply chain resilience. It also invests significantly in scientific engagement and medical education, fostering enduring relationships with healthcare professionals across India. The company continues to explore new therapy areas and regional expansions in response to evolving healthcare demands, maintaining a commitment to compliance and ethical practices.
Frequently Asked Questions – StockYaari Stock Page
Every stock page on StockYaari is built to give investors a complete picture of a company before they act on any idea. Below are the most common questions users ask about how this page works, what it shows, and how to make the most of it while researching a company.
Final Thoughts
Taken together, these sections are what make a StockYaari stock page useful for both quick decisions and deeper research. Whether someone is checking a live price during market hours, studying a company's fundamentals before investing for the long term, or simply confirming whether an analyst has an active call on a stock, everything sits in one organised place. New users are encouraged to explore each section at their own pace, since familiarity with the layout makes future research faster and more confident over time.
Track. Analyse. Outperform.
Your performance, our priority.

Platform Performance
(vs NIFTY 50)
Total Return
+24.35%
Outperformance
+12.41%
Accuracy
78%
Join 31,000+ active traders

Ready to unlock premium signals?
Sign in with your mobile number and start trading smarter today.

